44 results on '"Tay, Amy"'
Search Results
2. Single-cell landscape of functionally cured chronic hepatitis B patients reveals activation of innate and altered CD4-CTL-driven adaptive immunity
3. Switching to or Add-on Peginterferon in Patients on Nucleos(t)ide Analogues for Chronic Hepatitis B: The SWAP RCT
4. Bayesian analysis of cytokines and chemokine identifies immune pathways of HBsAg loss during chronic hepatitis B treatment
5. Data from Acquired Resistance to FGFR Inhibitor in Diffuse-Type Gastric Cancer through an AKT-Independent PKC-Mediated Phosphorylation of GSK3β
6. Table S1 from Acquired Resistance to FGFR Inhibitor in Diffuse-Type Gastric Cancer through an AKT-Independent PKC-Mediated Phosphorylation of GSK3β
7. Figure S3 from Acquired Resistance to FGFR Inhibitor in Diffuse-Type Gastric Cancer through an AKT-Independent PKC-Mediated Phosphorylation of GSK3β
8. Supplementary Figure 1 from CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
9. Supplementary Figure 4 from CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
10. Supplementary Table 1 from CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
11. Supplementary Table 3 from CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
12. Supplementary Figure 3 from CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
13. Supplementary Materials and Methods from CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
14. Supplementary Figure Legends from CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
15. Supplementary Table 2 from CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
16. Data from CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
17. Supplementary Figure 2 from CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
18. Supplementary Table 4 from CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
19. Longer Examination Time Improves Detection of Gastric Cancer During Diagnostic Upper Gastrointestinal Endoscopy
20. Roux-en-Y or Billroth II Reconstruction After Radical Distal Gastrectomy for Gastric Cancer: A Multicenter Randomized Controlled Trial
21. Single cell profiling of functionally cured Chronic Hepatitis B patients reveals the emergence of activated innate and an altered adaptive immune response in the intra-hepatic envrionment
22. Extensive peritoneal lavage after curative gastrectomy for gastric cancer (EXPEL): study protocol of an international multicentre randomised controlled trial
23. Endoscopic Tri-Modal Imaging Improves Detection of Gastric Intestinal Metaplasia Among a High-Risk Patient Population in Singapore
24. Dissecting the telomere region of barley chromosome 5HL using rice genomic sequences as references: new markers for tracking a complex region in breeding
25. A new PCR-based marker on chromosome 4AL for resistance to pre-harvest sprouting in wheat (Triticum aestivum L.)
26. Comparative biomarkers for HBsAg loss with antiviral therapy shows dominant influence of quantitative HBsAg (qHBsAg)
27. Erratum to: Endoscopic Tri-Modal Imaging Improves Detection of Gastric Intestinal Metaplasia Among a High-Risk Patient Population in Singapore
28. Acquired Resistance to FGFR Inhibitor in Diffuse-Type Gastric Cancer through an AKT-Independent PKC-Mediated Phosphorylation of GSK3β
29. Extensive peritoneal lavage after curative gastrectomy for gastric cancer (EXPEL): study protocol of an international multicentre randomised controlled trial
30. Su1152 Postoperative Complications Adversely Affect Long-Term Survival of Patients With Adenocarcinoma of the Gastroesophageal Junction (GEJ)
31. 412 Outcomes of Intraperitoneal and Systemic Chemotherapy for Patients with Peritoneal Metastases from Gastric Cancer: Is Conversion Surgery Possible?
32. 410 Roux-en-Y Versus Billroth II Gastrojejunostomy After Radical Distal Gastrectomy For Gastric Cancer - A Multicenter Randomized Controlled Trial
33. 987 Perioperative Outcomes After Billroth II Versus Roux-en-Y Reconstruction After Radical Distal Gastrectomy for Cancer - A Multi-Centre Randomized Controlled Trial
34. Abstract 1228: Clinical relevance of FGFR2 amplification in diffuse gastric cancer
35. Extensive peritoneal lavage after curative gastrectomy for gastric cancer (EXPEL): study protocol of an international multicentre randomised controlled trial.
36. 869 Discovery and Therapeutic Potential of FGFR2 Gene Amplification in Diffuse Gastric Cancer
37. CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells
38. Erratum to: Endoscopic Tri-Modal Imaging Improves Detection of Gastric Intestinal Metaplasia Among a High-Risk Patient Population in Singapore
39. The Discovery of CD44R as a Marker for Gastric Cancer Stem Cells
40. Abstract 3371: Gastric cancer stem/initiating cells are enriched in the CD44 fraction of EpCAM expressing cells
41. Dissecting the telomere region of barley chromosome 5HL using rice genomic sequences as references: new markers for tracking a complex region in breeding
42. A new PCR-based marker on chromosome 4AL for resistance to pre-harvest sprouting in wheat ( Triticum aestivum L.).
43. CD44v8-10 Is a Cancer-Specific Marker for Gastric Cancer Stem Cells.
44. Comparative biomarkers for HBsAg loss with antiviral therapy shows dominant influence of quantitative HBsAg (qHBsAg).
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.